Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction. | J Clin Invest;88(5): 1755-9, 1991 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.

Holodniy, M; Katzenstein, D A; Israelski, D M; Merigan, T C.

Affiliation

Holodniy M; Center for AIDS Research, Stanford University Medical Center, California 94305.

J Clin Invest ; 88(5): 1755-9, 1991 Nov.

Article in En | MEDLINE | ID: mdl-1682345

Subject(s)

HIV/genetics; Polymerase Chain Reaction; RNA, Viral/analysis; Zidovudine/therapeutic use; CD4-Positive T-Lymphocytes; HIV/drug effects; HIV Seropositivity/drug therapy; HIV Seropositivity/microbiology; Humans; Leukocyte Count

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Viral / Zidovudine / Polymerase Chain Reaction / HIV Limits: Humans Language: En Journal: J Clin Invest Year: 1991 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Viral / Zidovudine / Polymerase Chain Reaction / HIV Limits: Humans Language: En Journal: J Clin Invest Year: 1991 Type: Article